Covid-19

Updates on our COVID-19 Vaccines

small-molecule protein degraders

Sanofi Oncology: Looking Ahead

We asked Peter Adamson, Global Head of Oncology Development at Sanofi, to reflect on an extraordinary year and share his outlook for 2021

Full-Year 2020 Results & Capital Markets Day

The Q4 and full year 2020 results presentation and a strategy update at Capital Markets Day are available

Q4 Results

Inspired by Rare Disease Patients Around the World

More than 300 million people worldwide live with a rare disease, often feeling invisible and misunderstood. Find out how they are making a difference in the rare disease community

Indian Children

Sanofi’s Access to Healthcare Recognized in the ATM index

Sanofi takes a place in the top five companies of the 2021 Access to Medicine index

African family

A Two Decades-Long Fight Against Neglected Tropical Diseases

For the World Neglected Tropical Diseases Day, Sanofi celebrates the 20-year collaboration with WHO

  • Camera
    Press releases
    2021-02-26MMMM DD YYYY
    CHMP recommends approval of Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for the treatment of relapsed multiple myeloma

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK